Trial NCT02770014

View at ClinicalTrials.gov 
Org. Study IDs: 16-093

Last trial update was posted on 2019-11-22

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer

Stopping Reasons

Terminated due to Osimertinib approval

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID